P01857 (IGHG1_HUMAN) Homo sapiens (Human)

Immunoglobulin heavy constant gamma 1 UniProtKBInterProInteractive Modelling

330 aa; Sequence (Fasta)

Sequence Features

 103Interchain (with light chain).
 109Interchain (with heavy chain).
 112Interchain (with heavy chain).
 97K -> R (in IMGT allele IGHG1*03). VAR_003886
 239D -> E (in IMGT allele IGHG1*03). VAR_003887
 241L -> M (in IMGT allele IGHG1*03). VAR_003888
 27-83
 144-204
 250-308
 8-88Immunoglobulin C1-set
IPR003597PF07654
 123-211Immunoglobulin C1-set
IPR003597PF07654
 231-315Immunoglobulin C1-set
IPR003597PF07654

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-... Heteromer
P01834;
FUC;GAL;BMA;NAG;MAN;1hzh1-330
Solution structure of human Immunoglobulin M Heteromer
Q6PYX1;
2rcj1-326
Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgI... Heteromer
P08637;
FUC;BMA; 12×NAG;MLI;MAN;3sgj109-327
Engineered human IgG Fc domain glyco801 (Fc801) Heteromer
FUC;K;BMA;NAG;MAN;5v4e110-327
'Structure of FcgammaRI in complex with Fc reveals the importance of glycan recognition for high ... Heteromer
P12314;
FUL;BMA;NAG;MAN;4x4m112-329
'Crystal structure of nonfucosylated Fc complexed with bis-glycosylated soluble form of Fc gamma ... Heteromer
P08637;
FUC;GAL;BMA; 14×NAG;MAN;3ay4112-327
CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX Heteromer
O75015;
BMA;NAG;GLA;GAL;FUC;FUL;MAN;1e4k112-327
High-resolution crystal structure of Fc bound to its human receptor Fc-gamma-RI Heteromer
P12314;
GOL;ZN;BMA; 12×NAG;GAL;FUC;ACT;MAN;4w4o115-329
IgG1 Fc-FcgammaRI ecd complex Heteromer
P12314;
ZN; 15×NAG;FUL;MAN;4zne115-329
'Crystal structure of nonfucosylated Fc Y296W mutant complexed with bis-glycosylated soluble form... Heteromer
P08637;
BMA; 14×NAG;CL;GAL;FUC;MAN;5bw7113-327
'CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (... Heteromer
O75015;
BMA;NAG;NDG;GAL;FUC;FUL;MAN;1t89114-327
Complex of fcgammariia (CD32) and the FC of human IGG1 Heteromer
P12318;
GOL;BMA;NAG;NDG;SIA;GAL;FUL;MAN;3ry6114-327
'Unique carbohydrate/carbohydrate interactions are required for high affinity binding of FcgIII a... Heteromer
P08637;
BMA; 14×NAG;MLI;MAN;3sgk115-327
Crystal structure of IIb selective Fc variant, Fc(V12), in complex with FcgRIIb Heteromer
P31995;
GAL;FUL;BMA;NAG;MAN;3wjl115-327
'CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (... Heteromer
O75015;
BMA;NAG;HG2;NDG;GAL;FUL;MAN;1t83115-327
IgG Fc bound to 3 helix of the B-domain from Protein A Heteromer
P02976;
FUC;GAL;NAG;MAN;5u4y118-329
Crystal structure of IIb selective Fc variant, Fc(P238D), in complex with FcgRIIb Heteromer
P31994;
GAL;FUL;BMA;NAG;MAN;3wjj116-327
Crystal structure of asymmetrically engineered Fc variant in complex with FcgRIIIa Heteromer
P08637;
BMA; 12×NAG;GAL;FUL;IOD;MAN;3wn5116-327
Crystal Structure of an Autoimmune Complex between a Human IgM Rheumatoid Factor and IgG1 Fc reve... Heteromer
ZN;BMA;NAG;MPD;NDG;CD;GAL;ACT;CAC;FUL;MAN;2j6e119-329
G-2 glycovariant of human IgG Fc bound to minimized version of Protein A called Z34C Heteromer
FUL;BMA;NAG;MAN;1oqx119-328
Knob-into-hole IgG Fc Heteromer
4nqs118-327
'Crystal structure of the artificial protein AFFinger p17 (AF.p17) complexed with Fc fragment of ... Heteromer
FUC;GAL;BMA;NAG;MAN;3wkn119-328
Crystal structure of GASDALIE IgG1 Fc in complex with FcgRIIIa Heteromer
P08637;
BMA; 10×NAG;GAL;FUC;FUL;MAN;5d6d119-327
Ternary complex between Neonatal Fc receptor, serum albumin and Fc Heteromer
P02768; P55899; P61769;
FUL;BMA;NAG;MAN;4n0u119-327
'2 helix minimized version of the B-domain from Protein A (Z34C0 bound to IgG1 Fc (monoclinic form)' Heteromer
FUC;GAL;NAG;MAN;5u52119-326
BEAT Fc Heteromer
P01860;
GAL;FUL;BMA;NAG;MAN;5m3v120-327
Complex between G0 version of an Fc bound to a minimized version of Protein A called Mini-Z Heteromer
FUL;BMA;NAG;MAN;1oqo120-327
Crystal structure of extracellular domain of HER2 in complex with Fcab STAB19 Heteromer
P04626;
GOL;BMA; 12×NAG;MAN;5k33120-327
'FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C' Heteromer
GAL;FUL;BMA;NAG;MAN;1l6x120-326
COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC Heteromer
P19474;
FUC;GAL;BMA;NAG;MAN;2iwg120-326
Crystallographic Refinement and Atomic Models of a Human FC Fragment and its Complex with Fragmen... Heteromer
P38507;
FUC;GAL;MAN;SO4;NAG;1fc2121-327
Crystal structure of extracellular domain of HER2 in complex with Fcab H10-03-6 Heteromer
P04626;
5kwg120-326
Crystal Structure of a gE-gI/Fc complex Heteromer
P04488;
FUC;GAL;BMA;NAG;MAN;2gj7120-326
'CRYSTAL STRUCTURE OF THE C2 FRAGMENT OF STREPTOCOCCAL PROTEIN G IN COMPLEX WITH THE FC DOMAIN OF... Heteromer
P19909;
1fcc121-326
Anti-beta-amyloid antibody c706 fab in space group P21 Heteromer
3mcl1-107
Crystal structure of human anti-tau antibody CBTAU-27.1 Heteromer
P01834;
GOL;6dcv1-104
THREE-DIMENSIONAL STRUCTURE OF A HUMAN FAB WITH HIGH AFFINITY FOR TETANUS TOXOID Heteromer
P0DOY2;
1aqk1-103
48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID Heteromer
P01834;
NPE;1gaf1-103
IMMUNOGLOBULIN 48G7 GERMLINE FAB-AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY Heteromer
2rcs1-103
IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-... Heteromer
NPE;1aj71-103
ANTIBODY GNC92H2 BOUND TO LIGAND Heteromer
P01834;
COC;1i7z1-103
FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY Heteromer
P01834;
1hkl1-103
'STRUCTURE OF A HUMAN MONOCLONAL ANTIBODY FAB FRAGMENT AGAINST GP41 OF HUMAN IMMUNODEFICIENCY VIR... Heteromer
P01834;
1dfb1-103
Anti-beta-amyloid antibody c706 fab in space group c2 Heteromer
P01834;
3o111-103
'Crystal structure of broadly and potently neutralizing antibody VRC08 in complex with HIV-1 clad... Heteromer
P01834; Q8JDI3;
BU3; 11×NAG;4xmp1-102
Crystal structure of IL-23 in complex with neutralizing FAB Heteromer
P29460; Q9NPF7;
MPD;IMD;3d851-102
'Crystal structure of broadly and potently neutralizing antibody VRC08C in complex with HIV-1 cla... Heteromer
P01834; Q8JDI3;
11×NAG;4xny1-102
'Structure of redesigned IgG1 first constant and lambda domains (CH1:Clambda constant redesign 2 ... Heteromer
P0DOY2;
PG6;4llq1-101
'Structure of redesigned IgG1 first constant and lambda domains (CH1:Clambda constant redesign 1,... Heteromer
P0DOY2;
4llm1-101
Crystal structure of a disease-associated anti-human GM-CSF autoantibody MB007 Heteromer
P0DOY2;
4eow1-101
CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION Heteromer
P01834;
HOP;CD;1d6v1-101
'Crystal structure of human anti-tau antibody CBTAU-27.1 Fab in complex with a human tau peptide' Heteromer
A0A2K5IAM2; P01834;
6dcw1-101
UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY Heteromer
P01834;
CD;1d5i1-101
Crystal structure of a humanised 3D6 Fab bound to amyloid beta peptide Heteromer
P01834; P05067;
4hix1-101
MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN Heteromer
Q7Z3Y4;
HOP;CD;1axs1-101
UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY Heteromer
P01834;
CD;1d5b1-101
Crystal structure of broad and potent HIV-1 neutralizing antibody PGT128 in complex with a glycos... Heteromer
P04578; P0DOY2;
BMA;NAG; 11×MAN;3tyg1-101
'Crystal structure of broadly and potently neutralizing antibody VRC06B in complex with HIV-1 cla... Heteromer
P01834; Q0ED31;
NAG;FUC;4xnz1-101
AD related murine antibody Fragment Heteromer
P01647; P01808; P01834;
3u0w1-100
Crystal Structure of mid-region amyloid beta capture by solanezumab Heteromer
P01834; P05067;
4xxd1-100
Murine 6A6 Fab in complex with humanized anti-Tissue Factor D3H44 Fab Heteromer
G0YP42; P01863; Q7Z3Y4;
1pg71-100
Crystal Structure at 4.3 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env... Heteromer
P04578; P0DOY2;
SO4; 21×BMA; 108×NAG; 48×MAN;6de71-100
Structure of wild-type IgG1 antibody heavy chain constant domain 1 and light chain lambda constan... Heteromer
P0DOY2;
4lld3-101
Crystal structure of the anti-hinge rabbit antibody 2095-2 in complex with IDES hinge peptide Heteromer
GOL;4o4y113-119
'Crystal structure of the QAA variant of anti-hinge rabbit antibody 2095-2 in complex with IDES h... Heteromer
4o51114-119
Crystal structure of a human IgG1 Fc-fragment,high salt conditionhomo-4-mer GLA;FUL;BMA; 16×NAG; 10×MAN;1h3y121-327
F241A Fchomo-2-mer MAN;GAL;BMA;NAG;FUC;4q74113-326
Fc K392D/K409D homodimerhomo-2-mer SO4;5dvo117-328
'Crystal structure of monoclonal human anti-rhesus D Fc and IgG1 t125(yb2/0) in the presence of E...homo-2-mer GOL;GAL;NAG;MAN;3v95119-330
'Crystal structure of monoclonal human anti-rhesus D Fc IgG1 t125(yb2/0) double mutant (H310 and ...homo-2-mer GOL;GAL;NAG;MAN;3v8c119-330
Crystal Structure of the Fucosylated Fc Fragment from Human Immunoglobulin G1homo-2-mer FUC;ZN;BMA;NAG;MAN;3ave117-327
Crystal Structure of the Defucosylated Fc Fragment from Human Immunoglobulin G1homo-2-mer BMA;NAG;MAN;2dts117-327
Heterodimeric Fc Antibody Azymetric Variant 1homo-2-mer BMA;NAG;EDO;GAL;FUC;IOD;MAN;4bsv119-328
Heterodimeric Fc Antibody Azymetric Variant 2homo-2-mer BMA;NAG;EDO;GAL;FUC;IOD;MAN;4bsw119-328
Structural Characterization of a Human Fc Fragment Engineered for Lack of Effector Functionshomo-2-mer ZN;BMA;NAG;GAL;FUC;MAN;3c2s119-328
Fc fragment of IgG1 (Herceptin) with protein-A mimetic peptide dendrimer ligand.homo-2-mer FUC;X12;BMA;NAG;MAN;3d6g119-328
Human 1gG1 Fc fragment, 2.5 Angstrom structurehomo-2-mer GAL;FUL;BMA;NAG;MAN;3do3119-328
Enzyme deglycosylated Human IgG1 Fc fragmenthomo-2-mer 3dnk119-328
Glycosylated, disulfide-linked Hole-Hole Fc fragmenthomo-2-mer FUC;GAL;BMA;NAG;MAN;5hyi119-328
Glycosylated Knob-Knob Fc fragment (P6122)homo-2-mer GAL;BMA;NAG;FUC;5hyf118-326
Fc Heterodimer Design 7.8 D399M/Y407A + T366V/K409Vhomo-2-mer FUC;GAL;BMA;NAG;MAN;5djz118-326
monomeric Fchomo-2-mer BMA; 10×NAG;MAN;4j12119-327
human IgG1 Fc fragment Heterodimerhomo-2-mer FUC;BMA;NAG;MAN;4dz8119-327
Crystal structure of monoclonal human anti-Rhesus D Fc IgG1 T125(YB2/0) in the presence of Zn2+homo-2-mer GOL;ZN;NAG;GAL;MAN;IMD;3v7m119-327
Engineered human IgG Fc domain aglyco801homo-2-mer 5v43119-327
anti-CD20 monoclonal antibody Fc fragmenthomo-2-mer GAL;BMA;NAG;MAN;5iw6119-327
Wild type Fc (wtFc)homo-2-mer FUC;BMA;NAG;MAN;4q7d119-327
Crystal structure of a human Fc fragment engineered for extended serum half-lifehomo-2-mer FUC;BMA;NAG;MAN;3fjt119-327
Crystal Structure of an IgG1 Fc Glycoform (Man9GlcNAc2)homo-2-mer BMA;NAG;MAN;2wah120-328
Structural Characterization of a Mutated, ADCC-Enhanced Human Fc Fragmenthomo-2-mer ZN;BMA;NAG;GAL;FUC;MAN;2ql1119-327
Crystal structure of a chemoenzymatic glycoengineered disialylated Fc (di-sFc)homo-2-mer GAL;SIA;BMA;NAG;MAN;4q6y119-327
Crystal structure of human IgG1-Fchomo-2-mer GOL;BMA;NAG;PO4;GAL;FUC;MAN;5jii120-327
'Crystal structure of IgG Fc with a homogeneous glycoform and Antibody-Dependent Cellular Cytotox...homo-2-mer GAL;BMA;NAG;MAN;5gsq120-327
Glycosylated Knob-Knob Fc fragment (P212121)homo-2-mer GAL;BMA;NAG;FUC;5hye119-326
Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc (wild-type)homo-2-mer FUC;BMA;EDO;NAG;MAN;4wi2120-327
Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation H435Ahomo-2-mer FUC;BMA;EDO;NAG;MAN;4wi7120-327
Fc Knob-Hole Heterodimer T366W + T366S/L368A/Y407Vhomo-2-mer FUC;GAL;BMA;NAG;MAN;5di8120-327
'Role of the hinge and C-gamma-2/C-gamma-3 interface in immunoglobin G1 Fc domain motions: implic...homo-2-mer BMA;NAG;PG4;GAL;FUL;MAN;4ku1120-327
Fc Design 20.8.37 A chain homodimer Y349S/T366M/K370Y/K409Vhomo-2-mer 5dvl120-327
Fc Heterodimer Design 6.1 F405W/Y407A + T366Mhomo-2-mer FUC;GAL;BMA;NAG;MAN;5dj6120-327
anti-CD20 monoclonal antibody Fc fragmenthomo-2-mer BMA;NAG;GAL;SO4;ACT;MAN;5iw3119-326
anti-parallel Fc-hole(T366S/L368A/Y407V) homodimerhomo-2-mer 4nqt120-327
Fc Heterodimer Design 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407Ahomo-2-mer FUC;GAL;BMA;NAG;MAN;5djy120-327
Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation N434Ahomo-2-mer FUC;BMA;EDO;NAG;MAN;4wi6120-327
Fc Heterodimer Design 2.9 L368M/K370E + E357A/S364Ghomo-2-mer FUC;GAL;BMA;NAG;MAN;5djx120-327
Fc Heterodimer Design 11.2 Y349S/K370Y + E357D/S364Qhomo-2-mer FUC;GAL;BMA;NAG;MAN;5dj0120-327
Fc Heterodimer Design 5.1 T366V + Y407Fhomo-2-mer FUC;GAL;BMA;NAG;MAN;5djd120-327
Crystallographic structure of the Human Igg1 alpha 2-6 sialilated Fc-Fragmenthomo-2-mer GAL;FUL;BMA;NAG;MAN;4cdh119-326
Crystal Structure of Human IgG Fc Bearing Hybrid-type Glycanshomo-2-mer FUC;CL;BMA;NAG;MAN;4b7i120-327
Crystal structure of GASDALIE IgG1 Fchomo-2-mer FUC;GAL;BMA;NAG;MAN;5d4q120-327
Crystal structure of the human igg1 fc-fragment,glycoform (mn2f)2homo-2-mer FUL;BMA;NAG;1h3t121-328
CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (M3N2F)2homo-2-mer FUL;BMA;NAG;MAN;1h3u121-328
Fc Heterodimer Design 7.7 D399M/Y407A + T366V/K409Ihomo-2-mer FUC;GAL;BMA;NAG;MAN;5dj8120-327
CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G0F)2homo-2-mer FUL;BMA;NAG;MAN;1h3x121-328
Deactivation of human IgG1 Fc by endoglycosidase treatmenthomo-2-mer NAG;4acp120-327
Immunoglobulin Fc heterodimers varianthomo-2-mer MAN;BMA;NAG;FUC;4x99120-327
Immunoglobulin Fc heterodimer varianthomo-2-mer MAN;BMA;NAG;FUC;4x98120-327
anti-parallel Fc-knob (T366W) homodimerhomo-2-mer SO4;4nqu120-327
Fc K392D/K409D homodimerhomo-2-mer 5dvn120-327
Fc Heterodimer Design 7.4 Y407A + T366V/K409Vhomo-2-mer FUC;GAL;BMA;NAG;MAN;5dj2120-327
Fc Heterodimer E356K/D399K + K392D/K409Dhomo-2-mer FUC;GAL;BMA;NAG;MAN;5dk2119-326
Fc Design 7.7 B chain homodimer T366V/K409Ihomo-2-mer 5dvk120-327
Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation I253A/H310Ahomo-2-mer MAN;BMA;NAG;FUC;4wi9120-327
Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation I253Ahomo-2-mer FUC;BMA;NAG;MAN;4wi3120-327
Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation H310Ahomo-2-mer FUC;BMA;EDO;NAG;MAN;4wi5120-327
Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation Y436Ahomo-2-mer FUC;BMA;NAG;MAN;4wi8120-327
Fc Heterodimer Design 9.1 Y407M + T366Ihomo-2-mer FUC;GAL;BMA;NAG;MAN;5dja120-327
CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121homo-2-mer GAL;FUL;BMA;NAG;MAN;1h3v121-328
Aglycosylated human igg1 fc fragmenthomo-2-mer 3s7g119-326
Crystal structure of HER2 binding IgG1-Fc (Fcab STAB19)homo-2-mer FUC;BMA;NAG;MAN;5jih120-326
Crystal structure of human Fc at 1.80 Ahomo-2-mer FUC;GOL;BMA;NAG;MAN;4w4n120-326
Crystal structure of HER2 binding IgG1-Fc (Fcab H10-03-6)homo-2-mer BMA;NAG;MAN;5jik120-326
Fc Heterodimer Design 8.1 L368V/Y407A + T366V/K409Fhomo-2-mer FUC;GAL;BMA;NAG;MAN;5djc120-326
Fc Heterodimer Design 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407Ahomo-2-mer FUC;GAL;BMA;NAG;MAN;5dk0120-326
FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2homo-2-mer BMA;NAG;GAL;FUC;FUL;MAN;1dn2120-326
Structure of a Fc heterodimerhomo-2-mer FUC;GAL;BMA;NAG;MAN;5tps121-327
Glycosylated, disulfide-linked Knob-into-Hole Fc fragmenthomo-2-mer GAL;BMA;NAG;FUC;5hy9120-326
Structural mapping of the human IgG1 binding site for FcRn: hu3S193 Fc mutation S254Ahomo-2-mer FUC;BMA;EDO;NAG;MAN;4wi4121-327
CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMEN...homo-2-mer GAL;MAN;NAG;FUC;1fc1121-327
Fc Design 20.8.37 B chain homodimer E357D/S364R/Y407Ahomo-2-mer 5dvm120-326
'Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and s...homo-2-mer BMA;NAG;FUC;1h3w121-326
1.52 Angstrom Crystal Structure of Fc fragment of Human IgG1.homo-2-mer PGE;5hsf221-328
Structure of a Fc mutatntmonomer GAL;BMA;NAG;MAN;6f2z120-327
Modified single helix from the B-domain of protein A bound to IgG1 Fcmonomer GAL;BMA;NAG;MAN;5u66120-326
Crystal Structure of IgG Fc F241A mutant with native glycosylationmonomer FUL;BMA;CL;NAG;MAN;4bm7120-326
Crystal structure of sialylated IgG Fcmonomer BMA;NAG;CL;SIA;GAL;FUC;MAN;4byh121-327
Crystal Structure of an isolated, unglycosylated antibody CH2 domainmonomer 3dj9119-225